Tissue inhibitor of metalloproteinase-1 promotes cell proliferation through YAP/TAZ activation in cancer
出版年份 2017 全文链接
标题
Tissue inhibitor of metalloproteinase-1 promotes cell proliferation through YAP/TAZ activation in cancer
作者
关键词
-
出版物
ONCOGENE
Volume 37, Issue 2, Pages 263-270
出版商
Springer Nature
发表日期
2017-09-19
DOI
10.1038/onc.2017.321
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- The nonreceptor tyrosine kinase c-Src attenuates SCF(β-TrCP) E3-ligase activity abrogating Taz proteasomal degradation
- (2017) Matan Shanzer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Ameloblastin induces tumor suppressive phenotype and enhances chemosensitivity to doxorubicin via Src-Stat3 inactivation in osteosarcoma
- (2017) Toshinori Ando et al. Scientific Reports
- YAP/TAZ as therapeutic targets in cancer
- (2016) Francesca Zanconato et al. CURRENT OPINION IN PHARMACOLOGY
- Integrin signalling regulates YAP and TAZ to control skin homeostasis
- (2016) Ahmed Elbediwy et al. DEVELOPMENT
- TIMP1 is a prognostic marker for the progression and metastasis of colon cancer through FAK-PI3K/AKT and MAPK pathway
- (2016) Guohe Song et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Characterization of Hippo Pathway Components by Gene Inactivation
- (2016) Steven W. Plouffe et al. MOLECULAR CELL
- Integrin-YAP/TAZ-JNK cascade mediates atheroprotective effect of unidirectional shear flow
- (2016) Li Wang et al. NATURE
- PAK proteins and YAP-1 signalling downstream of integrin beta-1 in myofibroblasts promote liver fibrosis
- (2016) Katherine Martin et al. Nature Communications
- Tead and AP1 Coordinate Transcription and Motility
- (2016) Xiangfan Liu et al. Cell Reports
- Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer
- (2015) Fa-Xing Yu et al. CELL
- Adhesion to fibronectin regulates Hippo signaling via the FAK–Src–PI3K pathway
- (2015) Nam-Gyun Kim et al. JOURNAL OF CELL BIOLOGY
- A gp130–Src–YAP module links inflammation to epithelial regeneration
- (2015) Koji Taniguchi et al. NATURE
- Genome-wide association between YAP/TAZ/TEAD and AP-1 at enhancers drives oncogenic growth
- (2015) Francesca Zanconato et al. NATURE CELL BIOLOGY
- Disease implications of the Hippo/YAP pathway
- (2015) Steven W. Plouffe et al. TRENDS IN MOLECULAR MEDICINE
- TIMP-1 mediates TGF-β-dependent crosstalk between hepatic stellate and cancer cells via FAK signaling
- (2015) Sang-A Park et al. Scientific Reports
- The Neurofibromatosis 2 Tumor Suppressor Gene Product, Merlin, Regulates Human Meningioma Cell Growth by Signaling through YAP
- (2015) Katherine Striedinger et al. NEOPLASIA
- Mutant Gq/11 Promote Uveal Melanoma Tumorigenesis by Activating YAP
- (2014) Fa-Xing Yu et al. CANCER CELL
- Hippo-Independent Activation of YAP by the GNAQ Uveal Melanoma Oncogene through a Trio-Regulated Rho GTPase Signaling Circuitry
- (2014) Xiaodong Feng et al. CANCER CELL
- A Peptide Mimicking VGLL4 Function Acts as a YAP Antagonist Therapy against Gastric Cancer
- (2014) Shi Jiao et al. CANCER CELL
- The clinically used photosensitizer Verteporfin (VP) inhibits YAP-TEAD and human retinoblastoma cell growth in vitro without light activation
- (2014) Katarzyna Brodowska et al. EXPERIMENTAL EYE RESEARCH
- Metabolic control of YAP and TAZ by the mevalonate pathway
- (2014) Giovanni Sorrentino et al. NATURE CELL BIOLOGY
- Kaposi sarcoma-associated herpesvirus promotes tumorigenesis by modulating the Hippo pathway
- (2014) G Liu et al. ONCOGENE
- Geranylgeranylation signals to the Hippo pathway for breast cancer cell proliferation and migration
- (2014) W Mi et al. ONCOGENE
- The Biology of YAP/TAZ: Hippo Signaling and Beyond
- (2014) Stefano Piccolo et al. PHYSIOLOGICAL REVIEWS
- Downstream of Mutant KRAS, the Transcription Regulator YAP Is Essential for Neoplastic Progression to Pancreatic Ductal Adenocarcinoma
- (2014) W. Zhang et al. Science Signaling
- Serum tissue inhibitor of metalloproteinase 1 (TIMP-1) and vascular endothelial growth factor A (VEGF-A) are associated with prognosis in esophageal cancer patients
- (2013) M Kozłowski et al. Advances in Medical Sciences
- MT1-MMP-Dependent Control of Skeletal Stem Cell Commitment via a β1-Integrin/YAP/TAZ Signaling Axis
- (2013) Yi Tang et al. DEVELOPMENTAL CELL
- Timp1 interacts with beta-1 integrin and CD63 along melanoma genesis and confers anoikis resistance by activating PI3-K signaling pathway independently of Akt phosphorylation
- (2013) Mariana Toricelli et al. Molecular Cancer
- Tissue inhibitor of metalloproteinase 1 (TIMP-1) as a biomarker in gastric cancer: a review
- (2013) Mie Grunnet et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Regulation of the Hippo pathway and implications for anticancer drug development
- (2013) Hyun Woo Park et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Regulation of the Hippo-YAP Pathway by G-Protein-Coupled Receptor Signaling
- (2012) Fa-Xing Yu et al. CELL
- β-Catenin-Driven Cancers Require a YAP1 Transcriptional Complex for Survival and Tumorigenesis
- (2012) Joseph Rosenbluh et al. CELL
- Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP
- (2012) Y. Liu-Chittenden et al. GENES & DEVELOPMENT
- TGF-β synergizes with defects in the Hippo pathway to stimulate human malignant mesothelioma growth
- (2012) Makiko Fujii et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Reduced cell proliferation by IKK2 depletion in a mouse lung-cancer model
- (2012) Yifeng Xia et al. NATURE CELL BIOLOGY
- Tissue inhibitor of metalloproteinase-1 (TIMP-1) regulates mesenchymal stem cells through let-7f microRNA and Wnt/ -catenin signaling
- (2012) V. Egea et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Hitchhiker's Guide to Mechanobiology
- (2011) Jeroen Eyckmans et al. DEVELOPMENTAL CELL
- Role of YAP/TAZ in mechanotransduction
- (2011) Sirio Dupont et al. NATURE
- Elevated plasma tissue inhibitor of metalloproteinase-1 levels predict decreased survival in castration-resistant prostate cancer patients
- (2010) William K. Oh et al. CANCER
- A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF -TRCP
- (2010) B. Zhao et al. GENES & DEVELOPMENT
- Serum angiogenic profile of patients with glioblastoma identifies distinct tumor subtypes and shows that TIMP-1 is a prognostic factor
- (2010) M. Crocker et al. NEURO-ONCOLOGY
- Low expression of tissue inhibitor of metalloproteinases-1 (TIMP-1) in glioblastoma predicts longer patient survival
- (2009) Charlotte Aaberg-Jessen et al. JOURNAL OF NEURO-ONCOLOGY
- High levels of serum TIMP-1 correlate with advanced disease and predict for poor survival in patients with multiple myeloma treated with novel agents
- (2009) Evangelos Terpos et al. LEUKEMIA RESEARCH
- TEAD mediates YAP-dependent gene induction and growth control
- (2008) B. Zhao et al. GENES & DEVELOPMENT
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now